India, Dec. 23 -- image credit- freepik

Kashiv BioSciences, a biopharmaceutical company, has secured financing of Rs 648 crore from the Union Bank of India (UBI). The proceeds will be used to expand its state-of-the-art manufacturing facility in Pipan, near Ahmedabad, Gujarat.

The new single-use commercial manufacturing facility will be one of India's largest, equipped with cutting-edge technologies to support the production of high-quality biologics and specialty pharmaceuticals.

At full capacity, Kashiv expects the facility to manufacture up to 50,000L. This milestone represents a major step forward in Kashiv's mission to expand its global footprint and strengthen its position in India as a leading center for advanced biopharmaceutic...